Member Info for Laura2022

Ian67

I've added 72-74

Seller out any time now

Ignoring the green boxes

CODE woth a look

£6mln market cap ridiculous

Only 8mln shares hence one seller has brought this 200p to 70p

I've bought

Gross profit increased by 34% to £5.9 million (FY23: £4.4 million) with a gross profit margin of 67% (FY23: 63%) reflecting a balance between the efficiencies achieved by NCore and the economic challenges of inflation and rising operational costs.

· Adjusted EBITDA* increased significantly to £1.0 million (FY23: £0.1 million), in line with market expectations, and returned a positive profit after tax of £0.4 million (loss after tax FY23: £1.0 million)

· Cash balance as at 31 December 2024 of £1.2 million (FY23: £1.6 million)

· Net assets increased to £5.3 million (FY23: £4.8 million)

Eg SML did a huge diluted fund raise 3 weeks ago and you actually defended it

Trout

I don't and the evidence shows you don't hold PYC

You're yo be ignored

5mths ago GE bought some software for $51mln

PYC dosing app IP is clearly very undervalued ( separate from PYC core business)

Exactly that OSD

It's very odd that the only share Teout posts negatively on is here YET claims over last 5 weeks to have re bought a sizeable position

I think we can all see through his agenda

Yes OSD

As you say salaries and overheads one of lowest on AIM

Not quite sure why Trout has claimed to hold a sizeable position below 0.4p ( not that that's humanly possible) yet posted NOTHING yesterday but did post on SML and FAB

Trout, admit you're wrong please, this is from the actual PYC website

Laura2022

Posts: 9,689

Price: 0.425

No Opinion

RE: PYC - Artificial Intelligence (AI) Stock24 Apr 2025 08:09

We have developed a tool to help physicians understand the effect of the drug in specific patients and enable them to see the possible effect of changing doseCurrent personalised-dosing tools typically require costly additional assays and do not provide insight into toxicity or efficacy.

Personalised Dosing Tool Development

 

Data Identification

Identified public domain data on treatment of prostate cancer using docetaxel for 400+ patients from the comparator arm of a clinical trial

 

AI & Machine Learning

Applied AI techniques such as neural networks and other machine learning approaches to identify key factors linking dose, toxicity and efficacy

Troutisout1

They do use A.I , it's explicitly on their website

Why not just admit you don't actually hold and stop the pretense

Morning Trout

Surprised you didn't post yesterday with a 20%+ rise and your large position,

Just going to wait for the first TR1 (if any at all)

£600k BOD

I think I'll be taking 1st stake

Should be good now that PYC is on the radar if more people

You're clearly in too deep, I'll filter you and let's see who is right

Let's revisit after suspension

I don't need to, WG and "the market " have provided them since the apparent 35p deal

The market doesn't lie